Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2025 07:36 ET | Source: Research and Markets

Diabetes Drugs Industry Analysis with Regional Market Forecasts 2025-2033: An $113.63 Billion Global Opportunity

Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Drug Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
February 20, 2025 07:53 ET | Source: Research and Markets

Diabetes Drugs Market Trends, Opportunity, and Forecasts, 2024-2030: Launch of Novel Drug Classes like GLP-1 Receptor Agonists, SGLT2 Inhibitors, and DPP-4 Inhibitors Transforming the Landscape

Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
July 17, 2024 09:09 ET | Source: Research and Markets

Dementia with Diabetes Pipeline Therapeutics Market Report 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs

Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
May 24, 2024 07:07 ET | Source: Research and Markets

Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis

Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market Report by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis 2024-2032"...
April 23, 2024 04:01 ET | Source: Research and Markets

Global Prediabetes Treatment Market Analysis & Forecast Report 2024-2034

Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
April 15, 2024 11:18 ET | Source: Research and Markets

Global Prediabetes Market Analysis Report 2024-2030, Featuring Valbiotis, RESVERLOGIX, Caelus Health, SciMar, Boston Therapeutics, Aphaia Pharma, AstraZeneca and Bristol-Myers Squibb

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region,...
March 13, 2024 14:11 ET | Source: Research and Markets

Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added...
January 25, 2023 04:58 ET | Source: Research and Markets

Type 2 Diabetes Treatment Global Market Outlook Report 2022-2027: Combination of Next Generation Treatments, High Unmet Needs, & Premium Pricing to Drive Growth

Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market has been...
October 12, 2022 07:33 ET | Source: Research and Markets

The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030

Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
November 26, 2021 07:53 ET | Source: Research and Markets

Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108

Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...